Do insulin resistance and elevated triglycerides lower testosterone in men?

Metabolic health is a critical determinant of testicular endocrine function, with insulin sensitivity and lipid profiles directly influencing androgen synthesis.

Molecular mechanisms of insulin resistance

• Transcriptional repression: Chronic hyperinsulinemia shifts insulin's role in the testes from supportive to suppressive. Elevated insulin levels directly induce the nuclear receptor DAX-1 in Leydig cells.
• Suppression of key enzymes: DAX-1 acts as a transcriptional repressor that blocks LRH-1-driven transcription of critical steroidogenic genes, including StAR (steroidogenic acute regulatory protein), Cyp11a1, and 3β-HSD.
• Cellular stress: This molecular blockade limits mitochondrial cholesterol transport, the rate-limiting step in testosterone synthesis. Additionally, local insulin resistance triggers inflammatory cascades and NLRP3-mediated pyroptosis, reducing overall functional Leydig cell mass.

Role of hypertriglyceridemia and dyslipidemia

• Systemic and local inflammation: Elevated circulating triglycerides and elevated metabolic markers, such as the TyG-BMI (triglyceride-glucose-body mass index), are strongly associated with suppressed testosterone levels. Systemic dyslipidemia and visceral adiposity promote oxidative stress and chronic inflammation within the testicular microenvironment.
• Precursor depletion: This disruptive metabolic state alters lipid handling and depletes intracellular triglyceride and cholesterol ester pools in Leydig cells, depriving the steroidogenic machinery of the essential lipid precursors required for androgen synthesis.

Bottom line

• Insulin resistance and elevated triglycerides impair Leydig cell steroidogenesis through DAX-1-mediated transcriptional repression, local oxidative stress, and depleted cholesterol precursor pools, directly leading to lowered testosterone levels in men.